Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysisYue Chen, Tao Luo, Yu Li et al.|Frontiers in Immunology|2024Cited by 9